Horacio Cabral

USPTO Granted Patents = 5 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

2 out of 1,281

The University of Tokyo

patents

1 out of 566

Tokyo Institute of Technology

patents

1 out of 7

Kawasaki Institute of Industrial Promotion

patents

4. 1 out of 1,309

Japan Science and Technology Agency

where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10441662 - Polymer, method for producing polymer, and drug conjugate (2019-10-15),

2. 10220026 - Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer (2019-03-05),

3. 9801958 - Polymer nanoparticle composite and composition for MRI imaging including same (2017-10-31),

4. 8961949 - Polymer-metal complex composite having MRI contrast ability and MRI contrasting and/or antitumor composition using the same (2015-02-24),

5. 8012463 - Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same (2011-09-06),

Title: Horacio Cabral: Innovator in Polymer and Cancer Treatment Technologies

Introduction

Horacio Cabral is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of polymer science and cancer treatment. With a total of five patents to his name, his work focuses on developing innovative solutions for complex medical challenges.

Latest Patents

Cabral's latest patents include a novel polymer and a method for producing this polymer. The polymer features repeating units that are designed to enhance its functionality in various applications. Additionally, he has developed a micelle containing an epirubicin-complexed block copolymer, which serves as an anti-cancer agent. This pharmaceutical composition is particularly aimed at treating cancer, resistant cancer, or metastatic cancer. His inventions address the urgent need for effective therapies against epirubicin-resistant tumors.

Career Highlights

Throughout his career, Horacio Cabral has worked with esteemed institutions such as the University of Tokyo and the Tokyo Institute of Technology. His research has garnered attention for its potential impact on cancer treatment and polymer applications.

Collaborations

Cabral has collaborated with notable colleagues, including Kazunori Kataoka and Nobuhiro Nishiyama. Their joint efforts have contributed to advancements in the field of cancer therapeutics.

Conclusion

Horacio Cabral's innovative work in polymer science and cancer treatment exemplifies the importance of research and development in addressing critical health challenges. His contributions continue to pave the way for future advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.